The number of older Americans using vaping marijuana has nearly doubled in the past three years, according to new research supported by the American Association of Retired Persons (AARP). Most respondents said their main reasons for vaping marijuana include pain relief, improved sleep, and mental health. More than one in five Americans over the age […]
The number of older Americans using vaping marijuana has nearly doubled in the past three years, according to new research supported by the American Association of Retired Persons (AARP). Most respondents said their main reasons for vaping marijuana include pain relief, improved sleep, and mental health.
More than one in five Americans over the age of 50 have used marijuana at least once in the past year, and more than one in ten use it at least once a month, according to a University of Michigan survey. As more states move toward legalizing marijuana, researchers expect usage among older adults to continue to rise.
Among the respondents who used cannabis in the past year, 81% said it was for relaxation, 68% used it as a sleep aid, and 64% reported using it simply to enjoy the effects. Additionally, 63% indicated they used cannabis to relieve pain, while 53% said it helped promote mental health.
Jeffrey Kullgren, a professor at the University of Michigan and a doctor at the VA Ann Arbor Healthcare System, led the recent survey. He emphasized the importance of discussing cannabis use with healthcare providers to identify potential drug interactions and signs of problematic use.
Kullgren stated, “Even if your doctor, nurse practitioner, or pharmacist doesn’t ask about your cannabis use, it’s crucial to share this information, whether you use it for health issues or just for enjoyment. Many prescription and over-the-counter medications, as well as alcohol, can interact with cannabis and lead to unexpected effects. We have limited evidence showing the medical benefits of cannabis, but this may change over time.”
The University of Michigan also noted that reclassifying cannabis as a Schedule III substance under the Controlled Substances Act (CSA) could encourage more clinical trials involving human volunteers. However, such research is currently limited due to federal restrictions.
Earlier this year, a separate study found that cannabis products may offer various therapeutic benefits for older adults, including improvements in health, well-being, sleep, and mood. The authors of this study, published in the journal Drugs and Aging, noted significant reductions in pain severity and interference for older patients reporting chronic pain as their main issue.
CBD oil has surged in popularity across the UK, with over 6 million people, or 11% of the population, having used it in the past year. Though CBD oil seems like a recent trend, the cannabis plant has a long history, dating back 12,000 years, and has been used globally for millennia as a natural […]
Oct 12, 2024
Research shows that companies in states with medical marijuana can save thousands of dollars on health insurance premiums
Sep 29, 2024
Under the same smoking conditions, the particle sizes of 10 brands of electronic cigarettes are distributed in the range of 10~70nm, and the particle number concentration per unit volume is between 1.08×107~6.27×107·cm-3. The aerosol particle sizes are smaller than those of traditional cigarettes.
Sep 25, 2024
CBD, or cannabidiol, is a compound extracted from the cannabis plant. Is it a sports smoothie or a health booster? What exactly is CBD and why are people so keen on studying it?
Sep 20, 2024
The number of older Americans using vaping marijuana has nearly doubled in the past three years, according to new research supported by the American Association of Retired Persons (AARP). Most respondents said their main reasons for vaping marijuana include pain relief, improved sleep, and mental health. More than one in five Americans over the age […]
Sep 18, 2024
Recent Court Ruling: A Breakthrough for the Cannabis Industry The recent court ruling represents a significant victory for the hemp and cannabis industries, paving the way for product development and research. Specifically, the legalization of Delta-8 THC marks a pivotal point with potential for industry-wide change, offering new opportunities for market expansion. Medical Potential: Therapeutic […]
Sep 13, 2024
Nicotine replacement therapy, NRT is a type of medicine that delivers nicotine to the brain through nasal and oral sprays and inhalers.
Sep 12, 2024
At this point in time, with the global legalization of medical marijuana, its medical demand is growing rapidly. It is estimated that the global CBD output value will reach US$22 billion in 2022, a compound growth rate of 57% compared with 2019 (Source: Brightfield Group). According to the use of CBD: it can be divided […]
Sep 02, 2024
Global policies are gradually liberalized, and CBD consumption is increasing year by year. According to the use of cannabidiol (CBD): it can be divided into : medical CBD (used to treat epilepsy, Parkinson's disease and other diseases) and, consumer CBD (added to food, new tobacco and other consumer products). At this point in time, with […]
Aug 30, 2024
Cannabidiol (CBD) is a chemical substance derived from the cannabis plant, commonly known as marijuana or hemp. A particular type of CBD has been authorized in the United States as a medication for managing epilepsy. The cannabis plant is abundant in over 80 chemicals, collectively known as cannabinoids. Among them, Delta-9-tetrahydrocannabinol (THC) is the most […]
Aug 29, 2024
There are some reports that electronic cigarettes can cause some health problems in the lungs.
Jul 24, 2024
Inhaling artificial synthetic nicotine can satisfy the demand for nicotine or help quit smoking to a certain extent, and it can also reduce the harm to your own and others' health and the environment.
Jun 21, 2024
Several studies have shown that surface e-cigarettes cause damage to DNA .
Jun 19, 2024
(1.Shanghai Municipal Center for Health Promotion, Shanghai 200040, China; 2.Shanghai Association of Tobacco Control, Shanghai 200040, China; 3.Shanghai Municipal Health Commission, Shanghai 200125, China)
Jun 15, 2024
Department of Pulmonary and Critical Care Medicine, Peking University International Hospital, Beijing 102206, China
Jun 14, 2024
Nebulizing inhalation combined with non-invasive ventilation therapy in COPD patients with respiratory failure and nursing．
Jun 12, 2024
Aerosol administration during noninvasive ventilation (NIV) is a common clinical drug administration method, but the drug administration efficiency of different drug delivery devices is different.
Jun 05, 2024
Nasal aerosol inhalation is increasingly used in intensive care units (ICUs). In pediatric wards in the United States, 75% of patients receive nasal aerosol inhalation therapy, while the rest use traditional nebulization methods.
Jun 04, 2024
Nebulizer inhalation can humidify the respiratory tract, reduce inflammation, relieve cough and eliminate phlegm. It can also promote the absorption and excretion of inflammatory secretions. It has few side effects, shortens the course of the disease and has better therapeutic effects.
May 31, 2024
The study about the factors that affect the effect of nebulized inhalation by HFNC, among which VMN is more suitable for atomization inhalation therapy combined with HFNC.
May 30, 2024
Study on atomizing suction and atomizing particle size settling position，according to professional research data, the particle size of drug administration atomization into the lung is preferably 2-5 μm.
May 28, 2024
Here are some useful nebulizer medication guides which about chronic respiratory diseases such as asthma, bronchiectasis, and COPD.
May 24, 2024
Active smoking or passive exposure to second-hand smoke is one of the main risk factors for chronic obstructive pulmonary disease.
May 23, 2024
The nebulization process of the mesh nebulizer is gentler and less destructive.
May 17, 2024